Holen Sie sich die Stockscreener-App
89.70
1.21%
-1.085
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Abbott Laboratories Aktie (ABT) Neueste Nachrichten
AI Models Split on Abbott Laboratories (ABT) as Fundamentals Clash With Technical and Valuation Concerns - TipRanks
Abbott Laboratories (ABT) Receives FDA Clearance and CE Mark for Next-Generation Ultreon™ 3.0 Software - Yahoo Finance
Abbott–Exact Sciences, BioMarin–Amicus among deals cleared in Japan in Q1 - MLex
How Investors Are Reacting To Abbott (ABT) Gaining FDA, CE Clearance For AI-Guided Ultreon 3.0 - Yahoo Finance
Abbott Laboratories stock hits 52-week low at $90.72 - Investing.com
Abbott Laboratories stock hits 52-week low at $90.72 By Investing.com - Investing.com Australia
FDA Reports Baby Formula Safety, Highlights Abbott (ABT) Among C - GuruFocus
Abbott Receives FDA Clearance, CE Mark for Ultreon 3.0 AI Imaging Platform - AIM Media House
ABT SWOT Analysis: Key Insights from 10-Q Filing - GuruFocus
Abbott Laboratories (ABT) Stock Price, Trades & News - GuruFocus
FDA search for baby formula contamination finds little - Crain's Chicago Business
Abbott Laboratories (ABT) EVP reports 5,314-share trust move - Stock Titan
Ultreon 3.0 regulatory milestone sees Abbott Laboratories stock down 2.64% amid oversold conditions - Traders Union
[10-Q] ABBOTT LABORATORIES Quarterly Earnings Report - Stock Titan
Abbott Laboratories cuts outlook, says mild flu season hurt sales - MSN
Lawsuit Claims Abbott, Boston Scientific SCS Pre-Market Approval Supplements Caused Permanent Injuries - AboutLawsuits.com
Fund Update: 1,400,797 ABBOTT LABORATORIES (ABT) shares added to FLOSSBACH VON STORCH SE portfolio - Quiver Quantitative
symbol__ Stock Quote Price and Forecast - CNN
Abbott Laboratories Stock: Why Analysts Rate a Buy in 2026 - TIKR.com
Abbott’s Ultreon 3.0 AI Imaging Clearance And What It Means For Valuation - simplywall.st
Abbott’s FDA-Cleared Ultreon 3.0 Redefines Imaging in Coronary Interventions - The Indian Practitioner
Tuesday’s insider activity: Major sells at Avis Budget, buys at Abbott By Investing.com - Investing.com Canada
Tuesday’s insider activity: Major sells at Avis Budget, buys at Abbott - Investing.com
Here’s Why Polen Focus Growth Exited Abbott Laboratories (ABT) in Q1 - Yahoo Finance
Middle East and Africa Continuous Glucose Monitoring Market Forecast and Company Analysis Report 2026-2034 Featuring Dexcom, Medtronic, Senseonics, Abbott Diabetes Care, and GlySens - GlobeNewswire Inc.
Major Insider Move Signals Growing Confidence at Abbott Laboratories - TipRanks
Abbott (NYSE: ABT) awards director 2,286 restricted stock units - Stock Titan
Kevin Conroy (ABBOTT LABORATORIES: ABT) reports 131,451-share Form 3 holding - Stock Titan
Abbott Laboratories director Daniel Starks buys $926,537 in shares - Investing.com
Abbott Laboratories director Daniel Starks buys $926,537 in shares By Investing.com - Investing.com India
[Form 4] ABBOTT LABORATORIES Insider Trading Activity - Stock Titan
Abbott Laboratories (NYSE: ABT) director receives 2,286-share restricted stock unit award - Stock Titan
Abbott Laboratories (ABT) director gets RSU and option awards - Stock Titan
Abbott Laboratories (NYSE: ABT) grants shares and stock options to director - Stock Titan
Abbott (NYSE: ABT) director Darren McDew receives 2,286-share RSU award - Stock Titan
Abbott Laboratories (NYSE: ABT) director gets 2,286-share stock unit grant - Stock Titan
Director at Abbott Laboratories (NYSE: ABT) awarded 2,286 share-linked units - Stock Titan
Abbott Laboratories (NYSE: ABT) grants director 2,286 RSUs - Stock Titan
Director at Abbott Laboratories (NYSE: ABT) receives 2,286-share stock grant - Stock Titan
Abbott Laboratories stock (US0028241000): Why Google Discover changes matter more now - AD HOC NEWS
Abbott Laboratories (NYSE: ABT) director awarded 2,286 RSUs - Stock Titan
Steady action for Abbott Laboratories stock as price tests resistance levels near $93.37 - Traders Union
Abbott Laboratories Stock (ABT) Opinions on Q1 Earnings and Exact Sciences Acquisition - Quiver Quantitative
Saudi Arabia In-Vitro Diagnostics (IVD) Market Report - GlobeNewswire
Saudi Arabia In-Vitro Diagnostics (IVD) Market Report 2025-2034 Featuring Roche, Danaher, Abbott Laboratories, Thermo Fischer Scientific, Bio-Rad Laboratories, Sysmex, BD & Co, and Biomerieux - Yahoo Finance
Abbott gains FDA clearance, CE mark approval for AI-powered imaging platform - Cardiovascular Business
Abbott (ABT) Gains FDA and CE Approval for Ultreon 3.0 Software - GuruFocus
How to Pick a Healthcare Stock That Can Weather Any Market - The Globe and Mail
HbA1c Analyzer Market to Reach USD 1.6 Billion in 2026, Led - openPR.com
Abbott receives FDA clearance, CE Mark for AI imaging platform By Investing.com - Investing.com Canada
Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platform - Abbott MediaRoom
Abbott's AI tool pairs 1-second artery scans with stent guidance - Stock Titan
Late-Breaking AFib Data on Pulsed Field Ablation Could Be A Game Changer For Abbott (ABT) - simplywall.st
Point of Care Diagnostics Market | Abbott Laboratories, BD, Danaher Corp, Nova Biomedical Corporation etc. - openPR.com
Top Abbott Executive Makes Bold Insider Move at Abbott Laboratories - TipRanks
Abbott Laboratories (ABT) Announces New Board Member and Adoptio - GuruFocus
Proposed RSU sales by ABT insider via UBS (NYSE: ABT) on 04/27/2026 - Stock Titan
Abbott Laboratories EVP and CFO Philip Boudreau buys $201,300 in stock - Investing.com India
Abbott Laboratories EVP and CFO Philip Boudreau buys $201,300 in stock By Investing.com - Investing.com South Africa
Abbott (NYSE: ABT) CFO adds 2,200 shares in open-market buy - Stock Titan
Abbott Expands Board and Enhances Equity Incentive Programs - TipRanks
Abbott Laboratories stock outperforms competitors on strong trading day - MarketWatch
Abbott (NYSE: ABT) holders back 2026 stock plan, expand board - Stock Titan
Abbott's Strong AFib, Cardiac Device Data Fuels Heart-Rhythm Device Buzz - Benzinga
ABT Technical Analysis | Trend, Signals & Chart Patterns | ABBOTT LABORATORIES (NYSE:ABT) - ChartMill
Has the Abbott Laboratories sell-off finally created an entry point? - MSN
Abbott (ABT) Reports Promising Data on Heart Treatment Technologies - GuruFocus
Assessing Abbott (ABT) Valuation After New Cardiac Trial Results And Recent Share Price Pullback - simplywall.st
Teachers Retirement System of The State of Kentucky Trims Stock Position in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Bought by Vanguard Group Inc. - MarketBeat
Commentary: There is a hidden cost to the Abbott verdict for premature babies - Daily Republic
Concurrent Investment Advisors LLC Purchases 17,137 Shares of Abbott Laboratories $ABT - MarketBeat
Abbott Labs CEO makes $2M bet as stock sinks - MSN
4.81%
0.66%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):